Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment.
about
IL4 limits the efficacy of tumor-targeted antibody therapy in a murine model.Synergistic innate and adaptive immune response to combination immunotherapy with anti-tumor antigen antibodies and extended serum half-life IL-2.IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.Toll-like Receptor 4 Ligands Down-regulate Fcγ Receptor IIb (FcγRIIb) via MARCH3 Protein-mediated Ubiquitination.Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model.Combination strategies to enhance antitumor ADCC.Toll-like receptor-4 modulation for cancer immunotherapy.Anti-tumor Activity of Toll-Like Receptor 7 Agonists.TLR4-dependant immune response, but not hepatitis B virus reactivation, is important in radiation-induced liver disease of liver cancer radiotherapy.Antitumor Antibodies Can Drive Therapeutic T Cell Responses.Trastuzumab upregulates PD-L1 as a potential mechanism of trastuzumab resistance through engagement of immune effector cells and stimulation of IFNγ secretion.
P2860
Q34458331-259703DD-F5EF-4EE0-80B8-CAA70CEC418AQ35437978-DA11DE9C-7C63-40EE-A96A-9641579281A0Q35992493-C22E0FE9-1CCB-46A2-8EA4-729BE026578BQ36594664-DB30DF66-794C-41D5-9F5A-CB6603C21D93Q37634941-93E49816-C7A8-4780-87FB-CA89ABA42754Q38014085-96D2DC4F-6951-416D-B946-7E4E957AE8D8Q38239659-25FBBE4D-CFBB-4071-A1B6-D6C6430FB4C5Q39377049-7568EF6E-D931-4B30-A7BA-4B20EF234C4BQ42249102-B8353391-F1CE-4131-B13C-864E302ADB4CQ47722599-754A068B-F3C4-4BCC-98D6-17F181D903FBQ54979386-5A1252E3-CBAE-4708-89BF-FCBACC17E1AD
P2860
Effective antibody therapy induces host-protective antitumor immunity that is augmented by TLR4 agonist treatment.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Effective antibody therapy ind ...... ted by TLR4 agonist treatment.
@ast
Effective antibody therapy ind ...... ted by TLR4 agonist treatment.
@en
type
label
Effective antibody therapy ind ...... ted by TLR4 agonist treatment.
@ast
Effective antibody therapy ind ...... ted by TLR4 agonist treatment.
@en
prefLabel
Effective antibody therapy ind ...... ted by TLR4 agonist treatment.
@ast
Effective antibody therapy ind ...... ted by TLR4 agonist treatment.
@en
P2093
P2860
P1476
Effective antibody therapy ind ...... ted by TLR4 agonist treatment.
@en
P2093
Bruce A Littlefield
Catherine A Bingham
Igor A Astsaturov
Kenneth M McCarthy
Louis M Weiner
Lynn D Hawkins
R Katherine Alpaugh
Sally T Ishizaka
Shangzi Wang
P2860
P2888
P356
10.1007/S00262-011-1090-7
P577
2011-08-13T00:00:00Z